Q1 Revenue Jumps 30%, Losses Narrow, But Going Concern & Dilution Risks Persist
SCND has more than doubled off its 52-week low of $0.3 on light trading volume (0.1× avg).
Summary
Scientific Industries reported strong Q1 revenue growth and narrowed losses, but continues to face a 'going concern' warning and significant potential dilution from recent stock option grants.
Key Events · Earnings and Guidance · SCND
-
Strong Revenue Growth and Reduced Losses
First-quarter 2026 revenues increased by 30.2% year-over-year to $1.23 million, and the net loss narrowed to $(1.59) million from $(1.78) million in the prior year, driven by increased sales in both Benchtop Laboratory Equipment and Bioprocessing Systems segments and cost-cutting initiatives.
-
Ongoing Going Concern Warning
The company continues to disclose substantial doubt about its ability to continue as a going concern, although management believes cash from the 2025 Genie Division sale and related agreements will provide sufficient liquidity for at least one year.
-
Significant Stock Option Grants
1,112,000 ten-year stock options were granted on February 17, 2026, at an exercise price of $0.60. A majority of these (577,000) were granted to executives and the Board in lieu of cash salary and fees, contributing to potential dilution of approximately 9.3% of current outstanding shares from this grant alone.
-
Decreasing Liquidity
Cash and cash equivalents decreased to $797,800 as of March 31, 2026, from $955,000 at December 31, 2025. Net cash used in operating activities improved to $(993,500) from $(1,522,200) year-over-year.
Analysis · SCND · Industrial Applications And Services
This quarterly report details a significant 30.2% year-over-year revenue increase and a reduction in operating and net losses, indicating operational improvements. However, the company reiterates its 'going concern' warning, highlighting ongoing financial fragility despite management's belief in sufficient liquidity for the next year due to prior asset sales. The grant of over 1.1 million new stock options, some in lieu of cash compensation, introduces substantial potential dilution (approximately 9.3% of outstanding shares from this grant alone, and nearly 100% from all outstanding options/warrants if exercised) and underscores the company's cash conservation efforts.
At the time of this filing, SCND was trading at $0.75 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $8.9M. The 52-week trading range was $0.30 to $2.25. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.